Benjamin Graham fit · Investimento deep-value defensivo
Is Halozyme Therapeutics, Inc. (HALO) a Benjamin Graham Stock?
Meets 3/7 Graham criteria — partially qualifies.
46/100
DSinais mistos
3/7 critérios atendidos
Os critérios de Benjamin Graham, aplicados a HALO
P/E ≤ 15
chave—
P/B ≤ 1.5
chave15.0x
Current ratio ≥ 2
1.6x
Debt / Equity ≤ 1
0.0x
Como HALO pontua em outras estratégias
Dados financeiros ao vivo
Cap. de mercado
$8.38B
P/L (TTM)
20.4x
ROIC (TTM)
22.84%
Margem bruta
84.55%
Perguntas frequentes
What is HALO's Benjamin Graham fit score?
HALO scores 46/100 on our Benjamin Graham fit engine — grade D. Meets 3/7 Graham criteria — partially qualifies.
Does Benjamin Graham actually own HALO?
Our score is computed from financial fundamentals against Benjamin Graham's published criteria. We don't claim that Benjamin Graham personally owns or recommends HALO.
How often is this score updated?
HALO's Benjamin Graham fit score is recomputed daily from the latest TTM financials.
Ferramenta educacional, não é consultoria de investimento. As pontuações são calculadas a partir de dados financeiros públicos contra os critérios publicados de cada estratégia de investimento. Não afirmamos que Benjamin Graham possua ou recomende HALO pessoalmente.